USA Health Names Cancer Institute Director

USA Health named Dr. Martin J. Heslin director of its Mitchell Cancer Institute, effective February 15. USA Health says, “Heslin is a renowned surgical oncologist and former associate director of the O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham (UAB). He serves as executive vice chair of the Department of Surgery and is the chief of the medical staff at UAB Hospital. Heslin also is the James P. Hayes Jr. Endowed Professor in Gastrointestinal Oncology.” He has extensive training in hepatobiliary, pancreatic and colorectal surgery, and maintains a clinical interest in gastrointestinal cancers including liver, pancreas, stomach, colon and rectum malignancies. His research has focused on topics from surgical outcomes to physician management. He graduated from Cornell University in Microbiology and earned his medical degree from SUNY Health Science Center at Syracuse. He completed a general surgery residency at New York University Medical Center and holds a master’s degree in Health Administration from UAB. Heslin is author or coauthor on more than 120 publications and 10 book chapters.

Read More

Ainsworth To Speak At Forum Alabama

Ainsworth To Speak At Forum Alabama

Baldwin Alliance Earns Three Recognitions

Baldwin Alliance Earns Three Recognitions

Heircraft Seminar Coming To Innovation Portal

Heircraft Seminar Coming To Innovation Portal

EV Event Coming To Greer’s Market In Mobile

EV Event Coming To Greer’s Market In Mobile

Jeep Fest Coming To Gulf Shores

Jeep Fest Coming To Gulf Shores

Crockett Coming To Saenger

Crockett Coming To Saenger

ACF Outreach Event Coming To Mobile

ACF Outreach Event Coming To Mobile

SWIM Monitor Program Returning September 11

SWIM Monitor Program Returning September 11

Cheriogotis Announces Updates To Azalea City Golf Course

Cheriogotis Announces Updates To Azalea City Golf Course

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.